−100 KRW
−24.19 B KRW
160.35 B KRW
3.34 M
About CKD BIO CORPORATION
Sector
CEO
Wan-Gap Park
Headquarters
Seoul
Website
Founded
2001
ISIN
KR7063160006
FIGI
BBG000LDWB16
CKD Bio Corp. engages in the development and manufacture of active pharmaceutical ingredients and intermediates. Its products include antibiotics, beta-lactamase inhibitor, antidiabetic, and immunosuppressant. The company was founded on November 12, 2001 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 063160 is 22,400 KRW — it has decreased by −2.65% in the past 24 hours. Watch CKD BIO CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CKD BIO CORPORATION stocks are traded under the ticker 063160.
063160 stock has fallen by −2.44% compared to the previous week, the month change is a −2.87% fall, over the last year CKD BIO CORPORATION has showed a 1.59% increase.
063160 reached its all-time high on Dec 18, 2020 with the price of 119,000 KRW, and its all-time low was 2,300 KRW and was reached on Oct 28, 2008. View more price dynamics on 063160 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
063160 stock is 2.49% volatile and has beta coefficient of 0.81. Track CKD BIO CORPORATION stock price on the chart and check out the list of the most volatile stocks — is CKD BIO CORPORATION there?
Today CKD BIO CORPORATION has the market capitalization of 120.69 B, it has increased by 6.42% over the last week.
Yes, you can track CKD BIO CORPORATION financials in yearly and quarterly reports right on TradingView.
063160 net income for the last quarter is 285.22 M KRW, while the quarter before that showed 4.40 B KRW of net income which accounts for −93.52% change. Track more CKD BIO CORPORATION financial stats to get the full picture.
As of Dec 23, 2024, the company has 500.00 employees. See our rating of the largest employees — is CKD BIO CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CKD BIO CORPORATION EBITDA is 22.45 B KRW, and current EBITDA margin is −1.63%. See more stats in CKD BIO CORPORATION financial statements.
Like other stocks, 063160 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CKD BIO CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CKD BIO CORPORATION technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CKD BIO CORPORATION stock shows the sell signal. See more of CKD BIO CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.